Pushkal Garg; Chief Medical Officer, Executive Vice President - Development and Medical Affairs; Alnylam Pharmaceuticals Inc Jeffrey Poulton; Chief Financial Officer, Executive Vice President ...

NASHVILLE, Tenn., April 29, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2025 ...

Syndax Pharmaceuticals (NASDAQ:SNDX) is scheduled to announce Q1 earnings results on Monday, May 5th, after market close. The consensus EPS Estimate is -$1.27 and the consensus Revenue Estimate is ...

LINGAYEN, PANGASINAN—Joo Dae-yeong fended off multiple threats to narrowly cling onto the overall lead after a frenetic Stage 6 of the MPTC Tour of Luzon won by blue-chip Malaysian sprinter ...

Recursion Pharmaceuticals (NASDAQ:RXRX) is scheduled to announce Q1 earnings results on Monday, May 5nd, before market open. The consensus EPS Estimate is -$0.52 (-33.3% Y/Y) and the consensus ...

The Milwaukee Brewers' front office looks like geniuses right now, even with a .500 record. Milwaukee is 15-15 on the season so far after taking down the Chicago White Sox on Tuesday night.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Two years later, Kandi and Todd welcomed their first child together, Ace, in January 2016. Their younger daughter Blaze arrived in November 2019 via a surrogate. The Xscape singer’s children hav ...

Claim your 7-day free trial now. The United States Patent and Trademark Office (USPTO) issued patent number 12,274,692 to Adial Pharmaceuticals, Inc.’s ADIL AD04 on Thursday. The patent covers a ...

Tariffs already have many Americans concerned about the state of the economy, but the incoming taxes on pharmaceutical goods from China could present a more literal headache. More than 90% of the ...

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

--Down 11.5% month-to-date; on pace for worst month since Oct. 2024, when it fell 20.27% --Down 21.2% year-to-date --Down 53.29% from its all-time closing high of $1201.76 on Aug. 27, 2024 --Down ...